What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to officially announce Johnson & Johnson's (JNJ) fourth quarter and full-year 2023 financial results and to provide investors with access to the detailed financial information through attached exhibits, specifically a press release and supplementary sales and earnings data.

Where can I find the actual financial results and performance details?

The detailed financial results, including sales and earnings for the fourth quarter and full year ended December 31, 2023, are located in Exhibit 99.1 (the Press Release) and Exhibit 99.2 (Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings) which are attached to this 8-K filing.

Does this 8-K provide a summary of JNJ's performance?

While this 8-K is a formal SEC filing, it doesn't contain a narrative summary of the company's performance within the body of the report itself. Instead, it directs investors to the accompanying press release and supplementary financial statements for that analysis and the specific figures.

What is Exhibit 104 mentioned in the filing?

Exhibit 104 refers to the cover page of the Current Report on Form 8-K itself, formatted in Inline XBRL. This is a standard exhibit for enhanced data reporting.

JNJ 8-K: Earnings & Results

Summary

Johnson & Johnson (JNJ) filed an 8-K on January 23, 2024, to announce its fourth quarter and full-year 2023 financial results. The filing primarily directs investors to a press release (Exhibit 99.1) and supplementary financial data (Exhibit 99.2) containing detailed sales and earnings information for the periods ending December 31, 2023. Investors should review these attached documents for a comprehensive understanding of the company's performance, including revenue generation and profitability across its various segments.

Key Highlights

1JNJ announced its Q4 and full-year 2023 financial results on January 23, 2024.
2The 8-K filing primarily serves as a notification and directs readers to a detailed press release (Exhibit 99.1).
3Investors can find comprehensive sales and earnings information for the fourth quarter and the full year ended December 31, 2023.
4Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings are provided as Exhibit 99.2.
5The filing includes exhibits formatted in Inline XBRL for enhanced data accessibility.
6This report is an informational filing, with the core financial details residing in the attached press release and supplementary data.

JOHNSON & JOHNSON 8-K Report, Financial Results (Jan 23, 2024)

Summary

Key Highlights

Frequently Asked Questions